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Although great progress has been made in understanding the respiratory burst of leukocytes that produce superoxide (0-), it is possible that a com-
ponent, or components, might have been overlooked. Furthermore, 0° production and its sequels, though cardinal in bactericidal action, might ulti-
mately be damaging to the host's own cells. It is important, therefore, that a biologic mechanism exist to turn off 0° production by stimulated
leukocytes. This article offers evidence that methoxatin (P00), a redox-cycling orthoquinone, might be involved in 0° production by leukocytes. This
is based on the fact that inhibitors of 0° production, such as diphenylene iodonium (DPI) and 4,5-dimethylphenylene diamine (DIMPDA), were
shown to sequester PQQ in leukocytes, i.e., to form adducts with that substance. Addition of PQQ to cells blocked with the inhibitors partially
restored 0° release. With respect to turning off cellular °2 release, a factor was observed to be released to the medium by old macrophages (14
days old, but not by those less than 7 days old). Such conditioned medium, when added to stimulated neutrophils or macrophages, blocked 02
release. This factor was sensitive to proteases, exhibited molecular sizes of 3 and 11 kDa, and its action was independent of the nature of the stimu-
lus applied to the leukocytes. It was partially purified by column (sizing) chromatography and HPLC. It seems to be a general modulator of the
release of reactive oxygen species by phagocytes and is irrespective of phagocytic cellular type, or species from which the cells were derived.
Environ Health Perspect 102(Suppl 10):43-44 (1994)
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Introduction
Diphenylene iodonium (DPI) has been an
important and potent inhibitor of °-
release at approximately 50 pM (1). Its use
has contributed to our comprehension of
the mechanism by which leukocytes, stimu-
lated by particulate or soluble agents, elabo-
rate O°. Cross, for example, has adduced
evidence that a flavoprotein is involved by
showing that such a protein is labeled when
broken cells are exposed to 125I-DPI (2,3).
Other workers have indicated that the
labeling is less specific (4). As described
below, using somewhat different conditions
and tritiated DPI, we reached the conclu-
sion that methoxatin (PQQ) might be
involved. In other words, we wonder
whether the "turn on" mechanism is clear
yet, and in fact whether all the components
have been recognized so far (5).
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At the other end of the spectrum, we
considered the fact that °2 release from
stimulated leukocytes could be inimical to
host cells and tissues if it persisted beyond
its useful stage, i.e., its microbicidal func-
tion. Is there a biological mechanism to
turn O2 release off? Such indications do
exist in the literature (6-8). However, the
factor we have studied differs in molecular
weight and immediacy of action from fac-
tors obtained earlier (9).
Experimental
All substances used, cells employed, meth-
ods adopted, etc., have been outlined in
relevant earlier papers. Thus, synthetic
PQQ, tritiated PQQ and DIMPDA, as
well as the sizing columns and HPLC
methodology used, are described (10). The
cells from which the deactivating factor
was obtained, the mode of harvesting, the
steps of partial purification by ultrafiltra-
tion, gel filtration, and reversed-phase
HPLC, etc., are described (8,11).
Results
Tumningon0° Releaseby
Granulocytes2
DPI, DIMPDA, and diphenyliodonium all
inhibited °2 release from stimulated
guinea pig granulocytes, as expected (3).
DPI was the most potent inhibitor. As
reported, a 50-nM concentration resulted
in a 64% inhibition. A 1.5-pM solution of
inhibitor caused greater than 80% inhibi-
tion, which was relieved by addition of
PQQ in increasing amounts. By 100 pM
PQQ, inhibition was diminished by 50%.
When 16.5 pM tritiated DPI was incu-
bated with guinea pig granulocytes, the
pellet of cells retrieved and extracted, the
followingwere found:
-A water-soluble adduct of [3H]DPI and
PQQ was obtained. This was examined
by HPLC and was found to cochromato-
graph with an adduct of authentic PQQ
with [3H]DPI-PQQ. The adduct had a
unique HPLC profile.
* Exposure of the putative [H]DPI-PQQ
adduct to Tiron (a detergent) in excess
split out PQQ. Since this was not
radioactive, it was detected by its
absorbance profile and its redox charac-
teristics. The adduct itself had different
properties.
* No tritiated protein bands were seen on
SDS-gel ofthe extract ofthe cellular pel-
let after removal of the adduct of
[3H]DPI and PQQ.
These experiments were repeated with
[3H]DIMPDA, and supported by observa-
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tions in experiments in which the adducts
of tritiated PQQ and unlabeled inhibitors
were made in the test tube and compared
with the putative adduct of [3H]DPI and
endogenous PQQ.
These results seem highly suggestive
that PQQ has a role in the respiratory
burst of neutrophils, but do not represent
proof, as discussed below.
TurmingOff °2 Release
The factor that we have isolated has the
following characteristics:
* It is released to the medium by 14-day-
old macrophages on implanted glass cov-
erslips, but it can also be extracted from
the cells after sonication.
* The former preparation exhibits two
peaks of activity upon chromatography
on G-50 Sephadex. These had molecular
sizes corresponding to 3 and 11 kDa,
respectively. Only the former peak was
seen in the extracted factor.
* The 3-kDa material was examined fur-
ther and gave but a single peak ofactivity
on a reversed-phase HPLC column.
* The inhibition was concentration-depen-
dent with respect to the inhibitor.
* The factor was sensitive to pronase or
trypsin.
* It functioned against O2 release by stimu-
lated macrophages or neutrophils and was
not specific for species (human, mouse,
guinea pig cells were all inhibited).
Furthermore, its action was independent
of the nature of the stimulating factor
used (retinal, f-Met-Leu-Phe, phorbol
myristate acetate). These stimulating
agents operate by different modes.
Discussion
The first part ofthis article raises the possi-
bility that PQQ might participate in the
respiratory burst ofleukocytes. Against this
is the fact that reconstituted systems have
largely employed recombinant materials
(12,13). Nevertheless, the possibility that
some ubiquitous PQQ was present cannot
be excluded. Furthermore, the activity of
the reconstituted systems vis a visthe whole
cell is not quite apparent. Such evidence as
presented here, and more fully elsewhere
(10), together with the fact that PQQ has
previously been suggested to have a role in
the immune system, especially in white
cells (14), is tempting. Our calculations
from the data on adduct formation with
[3H]DPI suggest that the concentration in
granulocytes is about 300 times that in
plasma, i.e., 20 to 30 nm/108 cells. One
caveat in considering the whole question is
to remind oneself that the present data
derive from studies of guinea pig cells,
whereas most work on the mechanism of
°2 release by stimulated leukocytes has
been done on human cells.
Such concerns regarding species differ-
ences do not seem to apply in the case of
the turning offof°2 release by stimulated
macrophages. It should be noted that the
factor is so potent that its biological activity
is evident at concentrations at which the
protein involved cannot be measured.
Nevertheless, with some assumptions, it
can be calculated that it has been purified
at least 1000-fold.
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